Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
about
Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor CellsCharacterization of the Expression of the RNA Binding Protein eIF4G1 and Its Clinicopathological Correlation with Serous Ovarian CancerComprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver diseaseSpontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.Significant biomarkers for the management of hepatocellular carcinoma.Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.Proteomic profiling of retinoblastoma by high resolution mass spectrometry.The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.Spatially and temporally regulating translation via mRNA-binding proteins in cellular and neuronal function.IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma.RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer.Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer.
P2860
Q30938855-F9E781DB-6B58-4BDE-BE7A-60552AAEA0A5Q33652971-5645ABDF-D915-4D36-A5B9-0A2DD502698BQ33738850-C14B3AC7-5D77-41D4-953D-48023A7A2EAFQ34801745-412E7685-6BDE-435C-B40A-4361EB5F8549Q35494926-E5C9F773-BC93-432D-8F36-503FFF488B75Q35580808-062ACCC2-6FDA-4C8E-AD10-C6C1B6440D67Q35666404-7DF3857E-741A-4C22-B116-A75119FA2756Q35860992-D75B17CB-5407-4DB6-AD46-445235DB90C8Q36144493-7AB7AE36-9F5A-4647-AE1A-48BA720FE15EQ36561669-A0BFB2D1-8103-47A9-92C3-70C86C516798Q36597717-474D630B-5E63-4881-90D0-691B194B1C25Q37038522-DFAB5D5F-A1FD-45E3-8210-21F61D8F491BQ37507920-75240A25-5566-41D5-8286-39DF94F12914Q37708810-C82716D6-FF7B-45D8-91E8-27CDF0CB6687Q38412315-F9ABAD9B-AC86-4C11-844F-F46806731AE8Q38698051-155A3906-EFB2-4856-9C22-FC30E984B88BQ38734623-EF0ABB10-1CB8-42AC-9540-BBD993E5EA13Q38790943-9EC56F8B-B32C-4979-95D8-89716AE89AB0Q38854666-8A5A0FBB-2C3D-40F5-94E9-416A254DB288Q38937821-EFA32DDF-A076-4CFF-BCC0-896FC20346B8Q39179444-C0A087DC-780D-44F4-8690-74DE5F8CEE68Q40478066-F60FAAE9-2317-4A27-AB8C-A6296F170B0FQ46256483-B5A41DD2-CF08-4DAB-A060-C6DB0003AE41Q47113848-456C74FD-E7D7-406A-9D8C-7B79D28C6148Q52573382-CE54FA80-2959-40AF-B8B9-140C234B78FBQ52600941-B29C906C-9560-4499-B82E-621BC68A4EE2Q53764455-69AC28A2-7F29-443E-A65B-FEFD57FE4AF2Q55499961-13732ED0-710D-4B60-AB1D-85985F8567C7
P2860
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
description
article
@en
im April 2014 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована у квітні 2014
@uk
name
Insulin-like growth factor 2 m ...... or in hepatocellular carcinoma
@en
type
label
Insulin-like growth factor 2 m ...... or in hepatocellular carcinoma
@en
prefLabel
Insulin-like growth factor 2 m ...... or in hepatocellular carcinoma
@en
P2093
P2860
P356
P1433
P1476
Insulin-like growth factor 2 m ...... or in hepatocellular carcinoma
@en
P2093
Andreas Heim
Britta Mühleck
Britta Skawran
Evgenij Fiskin
Hannah Uckelmann
Matthias Groβ
Monika Hämmerle
Nadine Bley
Nikolaos Pazaitis
Nina Hofmann
P2860
P304
P356
10.1002/HEP.26997
P407
P577
2014-04-01T00:00:00Z